If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

  • There is currently no data for INDV

Director/PDMR Shareholding

13 Mar 2020 14:00

RNS Number : 1168G
Indivior PLC
13 March 2020
 

INDIVIOR PLC (THE 'COMPANY')

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM

The Company announces that on March 13, 2020, Conditional Awards ('Awards') over Ordinary Shares of $0.10 each ('Shares') were granted to the Executive Directors set out below under the Indivior Deferred Bonus Plan 2018 (the 'DBP').

Awards granted under the DBP represent the deferral of 25% of the gross bonus earned under the Indivior 2019 Annual Incentive Plan. The Awards will normally vest on the second anniversary of the Award date and are subject to continued employment. No consideration is payable either on the grant or vesting of the Awards.

Name

Number of Shares under Award

Executive Directors

Shaun Thaxter

488,656

Mark Crossley

188,523

 

This notification is made in accordance with the requirements of the EU Market Abuse Regulation.

Kathryn Hudson

Company Secretary

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Shaun Thaxter

 

2

 

Reason for the notification

 

 

a)

 

Position/status

  

Director / PDMR - Chief Executive Officer

 

b)

 

Initial notification /Amendment

Initial notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

 

Name

 

Indivior PLC

 

b)

 

LEI

 

213800V3NCQTY7IED471

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.10

 

 

GB00BRS65X63

 

b)

 

Nature of the transaction

Award over Ordinary Shares

 

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

N/A

488,656

 

d)

 

Aggregated information

 

- Aggregated volume

 

 - Price

 

 

N/A

 

e)

 

Date of the transaction

March 13, 2020

 

f)

 

Place of the transaction

 

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Mark Crossley

 

2

 

Reason for the notification

 

 

a)

 

Position/status

  

Director / PDMR - Chief Financial & Operations Officer

 

b)

 

Initial notification /Amendment

Initial notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

 

Name

Indivior PLC

 

b)

 

LEI

213800V3NCQTY7IED471

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.10

 

 

GB00BRS65X63

 

b)

 

Nature of the transaction

Award over Ordinary Shares

 

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

N/A

188,523

 

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

N/A

 

e)

 

Date of the transaction

March 13, 2020

 

f)

 

Place of the transaction

 

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGPUUAWUPUGGW
Date   Source Headline
15th Oct 20247:00 amRNSNotice of Results
15th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 202412:00 pmRNSPreliminary Q3 Results & Updated FY 2024 Guidance
8th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20242:30 pmRNSChair Succession Plan
1st Oct 20247:58 amRNSTotal Voting Rights
1st Oct 20247:00 amRNSTransaction in Own Shares
24th Sep 20247:00 amRNSTransaction in Own Shares
17th Sep 20247:00 amRNSTransaction in Own Shares
12th Sep 20247:00 amRNSHolding(s) in Company
10th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSIndivior Provides Update on AEF0117
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20249:00 amRNSTotal Voting Rights
27th Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:00 amRNSIndivior to Participate in Upcoming Events
14th Aug 20247:36 amRNSHolding(s) in Company
13th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSCompletion of Share Repurchase Program
6th Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20248:24 amRNSTotal Voting Rights
30th Jul 20242:31 pmRNSBlock Listings of Shares
30th Jul 20242:18 pmRNSDirector/PDMR Shareholding
30th Jul 20242:16 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20242:40 pmRNSDirector/PDMR Shareholding
29th Jul 20242:36 pmRNSDirector/PDMR Shareholding
29th Jul 20242:17 pmRNSDirector/PDMR Shareholding
29th Jul 20242:15 pmRNSDirector/PDMR Shareholding
26th Jul 20243:37 pmRNSDirector/PDMR Shareholding
26th Jul 20243:34 pmRNSDirector/PDMR Shareholding
25th Jul 20247:10 amRNSShare Repurchase Program
25th Jul 20247:00 amRNSHalf-year Report
23rd Jul 20247:00 amRNSTransaction in Own Shares
18th Jul 20244:26 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSNotice of Results
12th Jul 20247:00 amRNSHolding(s) in Company
11th Jul 20247:00 amRNSHolding(s) in Company
9th Jul 20247:00 amRNSIndivior Provides Business Update
9th Jul 20247:00 amRNSTransaction in Own Shares
5th Jul 20243:39 pmRNSHolding(s) in Company
3rd Jul 20241:56 pmRNSHolding(s) in Company
1st Jul 20249:44 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
28th Jun 202410:54 amRNSHolding(s) in Company
28th Jun 202410:32 amRNSHolding(s) in Company
28th Jun 20247:00 amRNSTransaction in Own Shares
27th Jun 20248:06 amRNSTransition to U.S. Primary Listing Complete

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.